98%
921
2 minutes
20
Skin cancer has one of the highest incidence rates among malignancies. A shortage of clinical expertise, particularly in primary care, contrasts with the promising performance of artificial intelligence (AI) models in assisting clinicians. However, a comprehensive evaluation of AI-based diagnostic accuracy across various skin cancers is essential before integration into routine clinical practice. This umbrella review synthesizes evidence from meta-analyses assessing AI model performance in skin cancer detection. We searched PubMed, Web of Science, and Embase for relevant meta-analyses published until January 28, 2025. We included 11 meta-analyses comprising 551 studies from various skin cancer types, clinical settings, and diagnostic modalities. Convolutional neural networks (CNN) and support vector machines (SVM) demonstrated the highest diagnostic performance, with CNN achieving the highest overall accuracy. AI models distinguishing melanoma from melanocytic lesions outperformed those detecting melanoma across all skin cancers, with SVM achieving the highest sensitivity (91%) and specificity (94%). For squamous cell carcinoma, machine learning models trained on hyperspectral imaging demonstrated the highest sensitivity (90.1%) and specificity (92.65%). In differentiating benign from malignant lesions, models exhibited a sensitivity of 87% and a specificity of 86.4%. AI-assisted approaches significantly improved diagnostic accuracy among all clinicians, with generalists and nurse practitioners benefiting more than experienced dermatologists. Deep learning models in primary care, trained on smartphone images, achieved higher sensitivity (90%) and specificity (85%) than general practitioners. AI models significantly outperformed junior dermatologists and nonspecialists compared to senior dermatologists. Hence, integrating AI-assisted tools into clinical workflows, particularly in primary settings, can enhance diagnostic accuracy and minimize missed cases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ijd.17981 | DOI Listing |
JAMA Dermatol
September 2025
Department of Population Health, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Importance: Increasingly, strategies to systematically detect melanomas invoke targeted approaches, whereby those at highest risk are prioritized for skin screening. Many tools exist to predict future melanoma risk, but most have limited accuracy and are potentially biased.
Objectives: To develop an improved melanoma risk prediction tool for invasive melanoma.
Ned Tijdschr Geneeskd
September 2025
Reinier de Graaf Gasthuis, afd. Dermatologie, Delft.
This case report describes the presence of an acquirednaevus of Ito on a 78-year-old Dutch male. Naevus of Ito is a blue-grey discolouration that most commonly presents on Asian individuals during childhood. It is exceedingly rare for this naevus to occur later in life in a non-Asian individual.
View Article and Find Full Text PDFInt J Dermatol
August 2025
Department of Dermatology, Mayo Clinic, Jacksonville, Florida, USA.
Endocr Rev
September 2025
Departments of Nutrition, Biochemistry and Molecular Medicine, University of Montreal, and Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
Glycerol and glycerol-3-phosphate are key metabolites at the intersection of carbohydrate, lipid and energy metabolism. Their production and usage are organismal and cell type specific. Glycerol has unique physicochemical properties enabling it to function as an osmolyte, protein structure stabilizer, antimicrobial and antifreeze agent, important to preservation of many biological functions.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
September 2025
School of Medicine, College of Medicine, Chung Shan Medical University, Taichung, Taiwan.